Luca Issi
Stock Analyst at RBC Capital
(0.15)
# 4,749
Out of 5,119 analysts
730
Total ratings
36%
Success rate
-5.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Reiterated: Hold | $130 → $145 | $254.19 | -42.96% | 44 | Nov 6, 2026 | |
| AGIO Agios Pharmaceuticals | Reiterated: Hold | $32 | $29.41 | +8.81% | 10 | Nov 5, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $9 | $1.04 | +765.38% | 34 | Nov 5, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $30 | $18.07 | +66.02% | 14 | Nov 5, 2026 | |
| KRRO Korro Bio | Reiterated: Hold | $10 | $14.75 | -32.20% | 17 | Nov 5, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Hold | $15 | $11.35 | +32.16% | 38 | Nov 5, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $19 | $7.62 | +149.34% | 41 | Nov 5, 2026 | |
| AMGN Amgen | Rated: Buy | $430 → $470 | $460.42 | +2.08% | 16 | Nov 4, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $19 | $15.43 | +23.14% | 23 | Nov 4, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $18 | $6.59 | +173.14% | 2 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $26.41 | -1.55% | 27 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $50.07 | -0.14% | 31 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 → $60 | $56.03 | +7.09% | 39 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $74.29 | +34.61% | 7 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $345 → $280 | $155.94 | +79.56% | 67 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.37 | +345.77% | 29 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,100 → $1,025 | $927.21 | +10.55% | 15 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 | $256.82 | +12.92% | 18 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $39.42 | +115.63% | 42 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.4487 | +122.87% | 24 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $48 | $21.70 | +121.20% | 45 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $58.16 | +71.94% | 41 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.89 | +592.04% | 15 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.57 | +55.64% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $4 | $3.70 | +8.11% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $0.114 | +1,654.39% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $9.00 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $54 | $9.25 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $3.50 | n/a | 7 | Mar 21, 2023 |
Moderna
Nov 6, 2026
Reiterated: Hold
Price Target: $130 → $145
Current: $254.19
Upside: -42.96%
Agios Pharmaceuticals
Nov 5, 2026
Reiterated: Hold
Price Target: $32
Current: $29.41
Upside: +8.81%
Allogene Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $9
Current: $1.04
Upside: +765.38%
Dyne Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $30
Current: $18.07
Upside: +66.02%
Korro Bio
Nov 5, 2026
Reiterated: Hold
Price Target: $10
Current: $14.75
Upside: -32.20%
Intellia Therapeutics
Nov 5, 2026
Reiterated: Hold
Price Target: $15
Current: $11.35
Upside: +32.16%
REGENXBIO
Nov 5, 2026
Reiterated: Buy
Price Target: $19
Current: $7.62
Upside: +149.34%
Amgen
Nov 4, 2026
Rated: Buy
Price Target: $430 → $470
Current: $460.42
Upside: +2.08%
Ultragenyx Pharmaceutical
Nov 4, 2026
Reiterated: Hold
Price Target: $19
Current: $15.43
Upside: +23.14%
Solid Biosciences
Nov 4, 2026
Reiterated: Buy
Price Target: $18
Current: $6.59
Upside: +173.14%
Nov 3, 2026
Reiterated: Hold
Price Target: $26
Current: $26.41
Upside: -1.55%
Nov 3, 2026
Reiterated: Hold
Price Target: $50
Current: $50.07
Upside: -0.14%
Nov 2, 2026
Reiterated: Hold
Price Target: $62 → $60
Current: $56.03
Upside: +7.09%
Oct 30, 2026
Reiterated: Buy
Price Target: $100
Current: $74.29
Upside: +34.61%
Oct 29, 2026
Rated: Buy
Price Target: $345 → $280
Current: $155.94
Upside: +79.56%
Oct 27, 2026
Reiterated: Buy
Price Target: $15
Current: $3.37
Upside: +345.77%
Oct 20, 2026
Rated: Buy
Price Target: $1,100 → $1,025
Current: $927.21
Upside: +10.55%
Oct 8, 2026
Reiterated: Buy
Price Target: $290
Current: $256.82
Upside: +12.92%
Oct 8, 2026
Reiterated: Buy
Price Target: $85
Current: $39.42
Upside: +115.63%
Oct 6, 2026
Downgraded: Hold
Price Target: $10 → $1
Current: $0.4487
Upside: +122.87%
Oct 2, 2026
Rated: Buy
Price Target: $65 → $48
Current: $21.70
Upside: +121.20%
Aug 30, 2026
Reiterated: Buy
Price Target: $100
Current: $58.16
Upside: +71.94%
Aug 12, 2026
Reiterated: Buy
Price Target: $20
Current: $2.89
Upside: +592.04%
Aug 5, 2026
Reiterated: Hold
Price Target: $4
Current: $2.57
Upside: +55.64%
Jun 2, 2026
Reiterated: Hold
Price Target: $10 → $4
Current: $3.70
Upside: +8.11%
May 14, 2026
Reiterated: Hold
Price Target: $2
Current: $0.114
Upside: +1,654.39%
Nov 13, 2024
Reiterated: Buy
Price Target: $9 → $11
Current: $9.00
Upside: n/a
May 11, 2023
Reiterated: Hold
Price Target: $3 → $54
Current: $9.25
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: $4 → $3
Current: $3.50
Upside: n/a